Reviv3 Procare Company

Company Profile

Reviv3 Procare Company had its IPO on under the ticker symbol RVIV.

The company operates in the Consumer Defensive sector and Household & Personal Products industry. Reviv3 Procare Company has a staff strength of 15 employees.

Stock update

Shares of Reviv3 Procare Company opened at $0.4 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.4 - $0.4, and closed at $0.4.

This is a 0% increase from the previous day's closing price.

A total volume of 15,310 shares were traded at the close of the day’s session.

In the last one week, shares of Reviv3 Procare Company have slipped by -11.11%.

Reviv3 Procare Company's Key Ratios

Reviv3 Procare Company has a market cap of $52.68 million, indicating a price to book ratio of 7.2734 and a price to sales ratio of 6.0232.

In the last 12-months Reviv3 Procare Company’s revenue was $23.52 million with a gross profit of $1.51 million and an EBITDA of $2.08 million. The EBITDA ratio measures Reviv3 Procare Company's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Reviv3 Procare Company’s operating margin was 8.44% while its return on assets stood at 22.42% with a return of equity of 53.22%.

In Q1.6666666666667, Reviv3 Procare Company’s quarterly earnings growth was a positive 193.2% while revenue growth was a positive 1208.9%.

Reviv3 Procare Company’s PE and PEG Ratio

Forward PE

0

Trailing PE

45

PEG

Its diluted EPS in the last 12-months stands at $0.01 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Reviv3 Procare Company’s profitability.

Reviv3 Procare Company stock is trading at a EV to sales ratio of 5.2763 and a EV to EBITDA ratio of 263.0303. Its price to sales ratio in the trailing 12-months stood at 6.0232.

Reviv3 Procare Company stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$10.17 million

Total Liabilities

$2.85 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Reviv3 Procare Company ended 2024 with $10.17 million in total assets and $0 in total liabilities. Its intangible assets were valued at $10.17 million while shareholder equity stood at $6.67 million.

Reviv3 Procare Company ended 2024 with $0 in deferred long-term liabilities, $2.85 million in other current liabilities, 11708.00 in common stock, $-3466992.00 in retained earnings and $2.15 million in goodwill. Its cash balance stood at $4.83 million and cash and short-term investments were $4.83 million. The company’s total short-term debt was $172,588 while long-term debt stood at $0.

Reviv3 Procare Company’s total current assets stands at $7.36 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $417016.00 compared to accounts payable of $908606.00 and inventory worth $1.31 million.

In 2024, Reviv3 Procare Company's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Reviv3 Procare Company paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.4

52-Week High

$0.7

52-Week Low

$0.2

Analyst Target Price

$

Reviv3 Procare Company stock is currently trading at $0.4 per share. It touched a 52-week high of $0.7 and a 52-week low of $0.7. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.45 and 200-day moving average was $0.42 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 8570.3% of the company’s stock are held by insiders while 1204.8% are held by institutions.